Stay updated on IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial
Sign up to get notified when there's something new on the IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial page.
Latest updates to the IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial page
- Check3 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.3%
- Check24 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check32 days agoChange DetectedThe I-DATA Study on IDH targeted vs non-targeted approaches in treating newly diagnosed IDH mutated AML patients has been updated with a new addition scheduled for 2024-12-31, replacing the previous entry set for 2024-03-04.SummaryDifference1%
- Check53 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check60 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
Stay in the know with updates to IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IDH-Targeted vs Non-Targeted Therapies in Newly Diagnosed AML Clinical Trial page.